Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record.

Multiple Endocrine Neoplasia--Syndromes of the Twentieth Century

Open access
Thakker, R. V.·1998·Journal of Clinical Endocrinology & Metabolism

Abstract

The multiple endocrine neoplasia (MEN) syndrome, which consists of several subtypes (Table 1), was first described in the early 1900’s, and during the century, the clinical features, biochemical characteristics, inheritance and genes, together with the encoded proteins for the MENs, have been defined (reviewed in references 1 and 2). Thus, the MENs represent syndromes of the 20th century, and the progress in these studies culminating with the four publications (3–6) in this issue will be reviewed. MEN is characterized by the occurrence of tumors involving two or more endocrine glands within a single patient. This disorder has previously been referred to as multiple endocrine adenopathy (MEA) and the pluriglandular syndrome. However, glandular hyperplasia and malignancy may also occur in some patients, and the term multiple endocrine neoplasia (MEN) is now the preferred term. There are two major forms of MEN, type 1 (MEN1, Wermer’s syndrome) and type 2 (MEN2, Sipple’s syndrome); each form is characterized by the development of tumors within specific endocrine glands (Table 1). The MEN syndromes are uncommon, but because they are inherited as autosomal dominant disorders, the finding of MEN in a patient has important implications for other family members; first degree relatives have about a 50% risk of developing the disease. Occasionally, the MEN syndromes may arise sporadically (i.e. without a family history). It may be difficult to make the distinction between sporadic and familial forms; in some cases the family history may be absent because the parent with the disease may have died before developing any manifestations. Thus, biochemical and genetic screening may have important roles in the lives of MEN patients and their families. The multiple endocrine neoplasia (MEN) syndromes, their characteristic tumors and associated genetic abnormalities Autosomal dominant inheritance of the MEN syndrome has been established. Del, deletion; ins, insertion. The multiple endocrine neoplasia (MEN) syndromes, their characteristic tumors and associated genetic abnormalities Autosomal dominant inheritance of the MEN syndrome has been established. Del, deletion; ins, insertion. MEN1 is characterized by the combined occurrence of tumors of the parathyroids, pancreatic islet cells, and anterior pituitary (reviewed in reference 1). Parathyroid tumors occur in 95% of MEN1 patients, resulting in the hypercalcemia of primary hyperparathyroidism. Parathyroid tumors detected by hypercalcemia are the first manifestation of MEN1 in about 90% of patients. Pancreatic islet cell tumors occur in 40% of MEN1 patients. Gastrinomas are the most common type, and insulinomas are the second most common. Glucagonomas and VIPomas are rare, whereas pancreatic polypeptidomas (PPomas) are more common but remain asymptomatic. Gastrinomas, leading to the Zollinger-Ellison syndrome, are the most important cause of morbidity and mortality in MEN1 patients. Anterior pituitary tumors occur in 30% of MEN1 patients. Most (60%) are prolactinomas, somatotrophinomas are the next most common (20%), and corticotrophinomas and nonfunctioning tumors represent less than 15% of MEN1 pituitary tumors. Associated tumors, which occur less commonly in MEN1, include adrenal cortical tumors (5%), carcinoid tumors (4%), lipomas (1%) angiofibromas (<1%), and collagenomas (<1%). The MEN1 gene. The gene causing MEN1 was localized to chromosome 11q13 by genetic mapping studies that investigated MEN1 associated tumors for loss of heterozygosity (LOH) and by segregation studies in MEN1 families (reviewed in reference 1). The results of these studies, which were consistent with Knudson’s model for tumor development, indicated that the MEN1 gene represented a putative tumor suppressor gene. Further genetic mapping studies defined a less than 300 Kb region as the minimal critical segment that contained the MEN1 gene, and characterization of genes from this region led to the identification of the MEN1 gene (7, 8), which consists of 10 exons with a 1,830 bp coding region that encodes a novel 610 amino acid protein, referred to as “MENIN” (7). Mutations of the MEN1 gene have been identified (7–10), and the study by Teh et al. (3), in this issue, reports a further 29 germ-line MEN1 mutations that were found amongst 58 MEN1 families and 8 sporadic MEN1 patients. Interestingly, a similar analysis of 8 families with isolated acromegaly and 4 families with isolated hyperparathyroidism did not detect any germ-line MEN1 mutations (3), and it seems likely that these 2 inherited endocrine disorders may have a different genetic etiology. The total number of germ-line mutations of the MEN1 gene that have now been identified (3, 7–10) in MEN1 patients is approximately 140 and approximately 25% are nonsense mutations, 45% are deletions, 15% are insertions, less than 5% are donor-splice mutations, and 10% are missense mutations. Thus, the majority (>80%) of these mutations are inactivating and a

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.83.8.2617

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 169

Metadata

Authors
Thakker, R. V.
Venue
Journal of Clinical Endocrinology & Metabolism
Published
1998-08-01
Volume
83
Issue
8
Pages
2617-2620
ISSN
0021-972X (ISSN-L)
OpenAlex
W2007264083
Cited by
169
References
0
FWCI
9.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple Endocrine Neoplasia--Syndromes of the Twentieth Century. https://app.cochat.ai/papers/10.1210/jc.83.8.2617
The paper
Thakker, R. V. (1998). Multiple Endocrine Neoplasia--Syndromes of the Twentieth Century. Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.83.8.2617

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.